Ascelia: Orviglance receives a CRL – our initial comment - Redeye
Bildkälla: Stockfoto

Ascelia: Orviglance receives a CRL – our initial comment - Redeye

Redeye comments on the disappointing news that Ascelia has received a CRL from the FDA for Orviglance. We place our valuation under review following this negative outcome and give a first comment.

Redeye comments on the disappointing news that Ascelia has received a CRL from the FDA for Orviglance. We place our valuation under review following this negative outcome and give a first comment.
Börsvärldens nyhetsbrev